Sign In
Buy ORGS
$0.590
+0.0950 (+19.19%)
At Close: Jun 03, 2026
Orgenesis. (ORGS) CEO Vered Caplan on Q4 2020 Results - Earnings Call Transcript
04:35pm, Tuesday, 09'th Mar 2021
Orgenesis. (ORGS) CEO Vered Caplan on Q4 2020 Results - Earnings Call Transcript
Orgenesis leads the charge at an exciting time for cell and gene therapy
02:21pm, Tuesday, 09'th Mar 2021
Global biotech unlocking the potential of personalized therapies and closed processing systems helpful in manufacturing Maryland-based firm has a Cell and Gene Therapy (CGT) Biotech platform The platf
Orgenesis Inc (NASDAQ:ORGS) (FRA:45O) announced Monday it has signed a collaboration agreement with Dong-a University Hospital in South Korea and Cure Therapeutics Inc to utilize Orgenesis Mobile Pro
GERMANTOWN, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and ge
Orgenesis Schedules Fiscal 2020 Year-End Business Update Conference Call
11:15am, Thursday, 04'th Mar 2021
GERMANTOWN, Md., March 04, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and ge
Orgenesis: A Cell And Gene Therapy Disruptor With A Nice Risk Reward Profile
06:08pm, Thursday, 28'th Jan 2021
Orgenesis is a $151m market cap biotech focused on cell and gene therapy technologies. It has a technology, therapeutics, and point of care platform that enables its CGT partners to develop products i
Orgenesis Third Quarter 2020 Revenue Increases 40% Reflecting Continued Progress of POCare Platform
08:30am, Thursday, 05'th Nov 2020
Reports rapid advancement of therapeutic pipeline
Orgenesis Announces Virtual 2020 Annual Meeting of Stockholders
03:15pm, Tuesday, 03'rd Nov 2020
GERMANTOWN, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene
Vetter Continues Its Long-term Investment Strategy to Sustain Future Growth
12:00am, Wednesday, 21'st Oct 2020
Vetter, a globally leading contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The
Investissement climatique : si ce n'est pas maintenant, quand ? Si ce n'est pas vous, qui ? - Actualités Asset Management
03:46pm, Monday, 12'th Oct 2020
Parmi les nombreux défis environnementaux, sociaux et de gouvernance (ESG) auxquels les entreprises sont aujourd’hui confrontées, il en est un qui éclipse tous les autres par son urgence....
Genital Warts Pipeline Insight Report 2020: Insights into 30 Companies & Pipeline Drugs - ResearchAndMarkets.com
12:00am, Friday, 09'th Oct 2020
The
Global CTB Review – A Cryptocurrency CFD Trading Broker ⋆ ZyCrypto
12:41pm, Friday, 02'nd Oct 2020
Global CTB is a trading platform that provides wide access to people for trading their assets in different markets. It provides you with
Trump tweets ‘Don’t buy Goodyear Tires’ after company bans workers from wearing MAGA attire
06:55pm, Wednesday, 19'th Aug 2020
Meanwhile, the presidential limo known as “The Beast” has had custom Goodyear Tires for decades
Goodyear's stock fall after Trump tweet urging boycott of company's tires, while rivals' shares gain
05:55pm, Wednesday, 19'th Aug 2020
Shares of Goodyear Tire & Rubber Co. undefined dropped 3.1% in afternoon trading Wednesday, after President Donald Trump urged people not to buy the tire...
Orgenesis Second Quarter 2020 Revenue Increases 55% Reflecting Progress of POCare Platform
11:30am, Friday, 07'th Aug 2020
Provides update on COVID-19 therapeutic programs Reports cash and cash equivalents of $97.5 million as of June 30, 2020GERMANTOWN, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS)
